• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病与可能的快速眼动睡眠行为障碍之间细胞外泌体α-突触核蛋白的不同模式。

Different patterns of exosomal α-synuclein between Parkinson's disease and probable rapid eye movement sleep behavior disorder.

机构信息

Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Department of Radiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Eur J Neurol. 2022 Dec;29(12):3590-3599. doi: 10.1111/ene.15537. Epub 2022 Sep 15.

DOI:10.1111/ene.15537
PMID:36047985
Abstract

BACKGROUND AND PURPOSE

The insidious onset of Parkinson's disease (PD) makes early diagnosis difficult. Notably, idiopathic rapid eye movement sleep behavior disorder (iRBD) was reported as a prodrome of PD, which may represent a breakthrough for the early diagnosis of PD. However, currently there is no reliable biomarker for PD diagnosis. Considering that α-synuclein (α-Syn) and neuroinflammation are known to develop prior to the onset of clinical symptoms in PD, it was hypothesized that plasma total exosomal α-Syn (t-exo α-Syn), neural-derived exosomal α-Syn (n-exo α-Syn) and exosomal apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC) may be potential biomarkers of PD.

METHODS

In this study, 78 PD patients, 153 probable iRBD patients (pRBD) and 63 healthy controls (HCs) were recruited. α-Syn concentrations were measured using a one-step paramagnetic particle-based chemiluminescence immunoassay, and ASC levels were measured using the Ella system.

RESULTS

It was found that t-exo α-Syn was significantly increased in the PD group compared to the pRBD and HC groups (p < 0.0001), whilst n-exo α-Syn levels were significantly increased in both the PD and pRBD groups compared to HCs (p < 0.0001). Furthermore, although no difference was found in ASC levels between the PD and pRBD groups, there was a positive correlation between ASC and α-Syn in exosomes.

CONCLUSIONS

Our results suggest that both t-exo α-Syn and n-exo α-Syn were elevated in the PD group, whilst only n-exo α-Syn was elevated in the pRBD group. Additionally, the adaptor protein of inflammasome ASC is correlated with α-Syn and may facilitate synucleinopathy.

摘要

背景与目的

帕金森病(PD)的隐匿发病使其早期诊断变得困难。值得注意的是,特发性快速眼动睡眠行为障碍(iRBD)被报道为 PD 的前驱期,这可能代表了 PD 早期诊断的一个突破。然而,目前尚无可靠的 PD 诊断生物标志物。鉴于α-突触核蛋白(α-Syn)和神经炎症在 PD 临床症状出现之前就已经发展,因此假设血浆总外泌体α-Syn(t-exo α-Syn)、神经源性外泌体α-Syn(n-exo α-Syn)和外泌体凋亡相关斑点样蛋白含有半胱氨酸天冬氨酸蛋白酶激活和募集结构域(ASC)可能是 PD 的潜在生物标志物。

方法

本研究纳入了 78 例 PD 患者、153 例可能的 iRBD 患者(pRBD)和 63 名健康对照者(HCs)。采用一步法基于顺磁微粒的化学发光免疫分析法测定 α-Syn 浓度,采用 Ella 系统测定 ASC 水平。

结果

与 pRBD 和 HCs 组相比,PD 组的 t-exo α-Syn 显著升高(p<0.0001),而 PD 和 pRBD 组的 n-exo α-Syn 水平均显著高于 HCs 组(p<0.0001)。此外,虽然 PD 和 pRBD 组之间 ASC 水平无差异,但外泌体中 ASC 与 α-Syn 呈正相关。

结论

本研究结果提示,PD 组的 t-exo α-Syn 和 n-exo α-Syn 均升高,而 pRBD 组仅 n-exo α-Syn 升高。此外,炎症小体衔接蛋白 ASC 与 α-Syn 相关,可能促进突触核蛋白病的发生。

相似文献

1
Different patterns of exosomal α-synuclein between Parkinson's disease and probable rapid eye movement sleep behavior disorder.帕金森病与可能的快速眼动睡眠行为障碍之间细胞外泌体α-突触核蛋白的不同模式。
Eur J Neurol. 2022 Dec;29(12):3590-3599. doi: 10.1111/ene.15537. Epub 2022 Sep 15.
2
A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.一项关于血浆神经元外泌体中α-突触核蛋白作为帕金森病发生和进展生物标志物的纵向研究。
Eur J Neurol. 2020 Jun;27(6):967-974. doi: 10.1111/ene.14208. Epub 2020 Apr 13.
3
SNCA Hypomethylation in Rapid Eye Movement Sleep Behavior Disorder Is a Potential Biomarker for Parkinson's Disease.快速眼动睡眠行为障碍中 SNCA 的低甲基化是帕金森病的潜在生物标志物。
J Parkinsons Dis. 2020;10(3):1023-1031. doi: 10.3233/JPD-201912.
4
Detection of α-Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder.通过种系扩增分析在突触核蛋白病和孤立性 REM 睡眠行为障碍中检测口腔黏膜中的 α-突触核蛋白。
Mov Disord. 2024 Aug;39(8):1300-1309. doi: 10.1002/mds.29828. Epub 2024 May 7.
5
Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson's disease.睡眠障碍与前驱期和早期帕金森病患者脑脊液 α-突触核蛋白的相关性。
J Neurol. 2022 May;269(5):2469-2478. doi: 10.1007/s00415-021-10812-2. Epub 2021 Oct 4.
6
Oligomeric Alpha-Synuclein and STX-1A from Neural-Derived Extracellular Vesicles (NDEVs) as Possible Biomarkers of REM Sleep Behavior Disorder in Parkinson's Disease: A Preliminary Cohort Study.神经源性细胞外囊泡(NDEVs)中的寡聚化α-突触核蛋白和 STX-1A 作为帕金森病 REM 睡眠行为障碍的可能生物标志物:一项初步队列研究。
Int J Mol Sci. 2023 May 16;24(10):8839. doi: 10.3390/ijms24108839.
7
Detecting Misfolded α-Synuclein in Blood Years before the Diagnosis of Parkinson's Disease.在帕金森病诊断前数年的血液中检测到错误折叠的α-突触核蛋白。
Mov Disord. 2024 Aug;39(8):1289-1299. doi: 10.1002/mds.29766. Epub 2024 Apr 23.
8
[Alterations in erythrocytic oligomeric alpha-synuclein in patients with Parkinson's disease and multiple system atrophy].[帕金森病和多系统萎缩患者红细胞寡聚α-突触核蛋白的改变]
Zhonghua Yi Xue Za Zhi. 2023 Oct 10;103(37):2933-2939. doi: 10.3760/cma.j.cn112137-20230607-00957.
9
Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.皮肤磷酸化α-突触核蛋白沉积证实快速眼动睡眠行为障碍为帕金森病前驱症状。
Acta Neuropathol. 2017 Apr;133(4):535-545. doi: 10.1007/s00401-017-1684-z. Epub 2017 Feb 8.
10
Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson's Disease.血浆 L1CAM 外泌体中的长链非编码 RNA POU3F3 和 α-突触核蛋白与β-葡糖脑苷脂酶活性的结合:帕金森病的潜在预测因子。
Neurotherapeutics. 2020 Jul;17(3):1104-1119. doi: 10.1007/s13311-020-00842-5.

引用本文的文献

1
Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinson's disease.帕金森病轻度认知障碍早期诊断中多模态生物标志物的研究进展
Front Neurol. 2025 Aug 29;16:1652378. doi: 10.3389/fneur.2025.1652378. eCollection 2025.
2
Brain-derived extracellular vesicles: A promising avenue for Parkinson's disease pathogenesis, diagnosis, and treatment.脑源性细胞外囊泡:帕金森病发病机制、诊断和治疗的一条有前景的途径。
Neural Regen Res. 2025 Apr 29. doi: 10.4103/NRR.NRR-D-24-01262.
3
A Narrative Review on Biochemical Markers and Emerging Treatments in Prodromal Synucleinopathies.
前驱性突触核蛋白病的生化标志物与新兴治疗方法的叙述性综述
Clin Pract. 2025 Mar 17;15(3):65. doi: 10.3390/clinpract15030065.
4
Biology, Pathology, and Targeted Therapy of Exosomal Cargoes in Parkinson's Disease: Advances and Challenges.帕金森病中外泌体所载物质的生物学、病理学及靶向治疗:进展与挑战
Mol Neurobiol. 2025 Feb 25. doi: 10.1007/s12035-025-04788-7.
5
Shared and distinct changes in the molecular cargo of extracellular vesicles in different neurodegenerative diseases.不同神经退行性疾病中细胞外囊泡分子货物的共同和独特变化。
Cell Mol Life Sci. 2024 Dec 3;81(1):479. doi: 10.1007/s00018-024-05522-7.
6
Circadian rhythm disruption: a potential trigger in Parkinson's disease pathogenesis.昼夜节律紊乱:帕金森病发病机制中的一个潜在触发因素。
Front Cell Neurosci. 2024 Oct 30;18:1464595. doi: 10.3389/fncel.2024.1464595. eCollection 2024.
7
Measurement of α-synuclein as protein cargo in plasma extracellular vesicles.血浆细胞外囊泡中α-突触核蛋白作为蛋白货物的测量。
Proc Natl Acad Sci U S A. 2024 Nov 5;121(45):e2408949121. doi: 10.1073/pnas.2408949121. Epub 2024 Oct 30.
8
The potential of exosomal biomarkers: Revolutionizing Parkinson's disease: How do they influence pathogenesis, diagnosis, and therapeutic strategies?外泌体生物标志物的潜力:革新帕金森病:它们如何影响发病机制、诊断和治疗策略?
AIMS Neurosci. 2024 Sep 23;11(3):374-397. doi: 10.3934/Neuroscience.2024023. eCollection 2024.
9
α-Synuclein species in plasma neuron-derived extracellular vesicles as biomarkers for iRBD.血浆神经元来源细胞外囊泡中的 α-突触核蛋白作为 iRBD 的生物标志物。
Ann Clin Transl Neurol. 2024 Nov;11(11):2891-2903. doi: 10.1002/acn3.52200. Epub 2024 Sep 18.
10
Extracellular vesicles from bodily fluids for the accurate diagnosis of Parkinson's disease and related disorders: A systematic review and diagnostic meta-analysis.用于帕金森病及相关疾病准确诊断的体液细胞外囊泡:一项系统评价与诊断性荟萃分析
J Extracell Biol. 2023 Nov 13;2(11):e121. doi: 10.1002/jex2.121. eCollection 2023 Nov.